Qingbo Meng, David Bogle, Vassilis M. Charitopoulos
{"title":"Probabilistic design space exploration and optimization via bayesian approach for a fluid bed drying process","authors":"Qingbo Meng, David Bogle, Vassilis M. Charitopoulos","doi":"10.1016/j.ejps.2025.107116","DOIUrl":null,"url":null,"abstract":"<div><div>The concept of Design Space (DS), delineated as a region of investigated variables aimed at maintaining product quality, was introduced in the International Conference on Harmonisation (ICH) Q8 as a framework to direct pharmaceutical development. However, the complexity of processes and the presence of uncertainties in pharmaceutical manufacturing exacerbate the difficulties of exploring a reliable and robust DS. This study investigates the probabilistic design space to explain the process operability and performance reliability using a Bayesian approach for a fluid bed drying process. We initially develop a Bayesian model by integrating a surrogate-based predictive model with embedded uncertainty quantification of material variability. Subsequently, employing a grid search-based technique to discretize the operational variable domain facilitates the exploration of the probabilistic DS to meet the specified product quality requirements. Meanwhile, optimization is employed to obtain the maximum DS region and enhance its operability. Results demonstrate that the Bayesian approach is an effective method to identify a probability DS to guarantee product quality at the desired reliability level considering material and process uncertainty.</div></div>","PeriodicalId":12018,"journal":{"name":"European Journal of Pharmaceutical Sciences","volume":"210 ","pages":"Article 107116"},"PeriodicalIF":4.3000,"publicationDate":"2025-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Pharmaceutical Sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0928098725001150","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
The concept of Design Space (DS), delineated as a region of investigated variables aimed at maintaining product quality, was introduced in the International Conference on Harmonisation (ICH) Q8 as a framework to direct pharmaceutical development. However, the complexity of processes and the presence of uncertainties in pharmaceutical manufacturing exacerbate the difficulties of exploring a reliable and robust DS. This study investigates the probabilistic design space to explain the process operability and performance reliability using a Bayesian approach for a fluid bed drying process. We initially develop a Bayesian model by integrating a surrogate-based predictive model with embedded uncertainty quantification of material variability. Subsequently, employing a grid search-based technique to discretize the operational variable domain facilitates the exploration of the probabilistic DS to meet the specified product quality requirements. Meanwhile, optimization is employed to obtain the maximum DS region and enhance its operability. Results demonstrate that the Bayesian approach is an effective method to identify a probability DS to guarantee product quality at the desired reliability level considering material and process uncertainty.
期刊介绍:
The journal publishes research articles, review articles and scientific commentaries on all aspects of the pharmaceutical sciences with emphasis on conceptual novelty and scientific quality. The Editors welcome articles in this multidisciplinary field, with a focus on topics relevant for drug discovery and development.
More specifically, the Journal publishes reports on medicinal chemistry, pharmacology, drug absorption and metabolism, pharmacokinetics and pharmacodynamics, pharmaceutical and biomedical analysis, drug delivery (including gene delivery), drug targeting, pharmaceutical technology, pharmaceutical biotechnology and clinical drug evaluation. The journal will typically not give priority to manuscripts focusing primarily on organic synthesis, natural products, adaptation of analytical approaches, or discussions pertaining to drug policy making.
Scientific commentaries and review articles are generally by invitation only or by consent of the Editors. Proceedings of scientific meetings may be published as special issues or supplements to the Journal.